Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
18 results
  • Breast Cancer, Bladder Cancer, Endometrial Cancer, Ovarian Cancer

17-392          Phase I

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-033, an Anti-LAG-3 Monoclonal Antibody, Alone and in Combination With an Anti-PD-1 in Patients With Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Lung Cancer, Endometrial Cancer, Breast Cancer, Ovarian Cancer

16-393          Phase I

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Ovarian Cancer, Endometrial Cancer

19-163          Phase I

A Phase 1 Multicenter, Open-Label, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AO-176 (View details on clinicaltrial.gov)

  • Ovarian Cancer

18-227          Phase II

A Phase 1/2 Study of REGN4018 Administered Alone or in Combination with Cemiplimab in Patients with Platinum-Resistant Ovarian Cancer (View details on clinicaltrial.gov)

  • Ovarian Cancer, Lung Cancer, Endometrial Cancer

18-555          Phase I

A Phase 1a/1b Study of COM701 as Monotherapy and In Combination with an Anti-PD-1 Antibody in Subjects with Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Ovarian Cancer

18-554          Phase II

A Phase 1b/2 Randomized, Controlled Study Of Avb-S6-500 In Combination With Pegylated Liposomal Doxorubicin Or Paclitaxel In Patients With Platinum-Resistant Recurrent Ovarian Cancer (View details on clinicaltrial.gov)

  • Ovarian Cancer

18-303          Phase II

A Phase 2 Multicohort Study to Evaluate the Safety and Efficacy of Novel Treatment Combinations in Patients with Recurrent Ovarian Cancer (View details on clinicaltrial.gov)

  • Ovarian Cancer

19-408          Phase II

A Phase 2 Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and TSR-042 in Patients With Platinum-Resistant Ovarian Cancer (MOONSTONE) (View details on clinicaltrial.gov)

  • Ovarian Cancer

17-499          Phase II

A Phase 2 Study Evaluating the Efficacy and Safety of DKN-01 as a Monotherapy or in Combination with Paclitaxel in Patients With Relapsed/ Refractory Endometrioid Endometrial or Endometrioid Ovarian Cancer (View details on clinicaltrial.gov)

  • Ovarian Cancer

19-210          Phase II

A Phase 2, Randomized, Open-label, 3-arm Study of Relacorilant in Combination with Nab-Paclitaxel for Patients with Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (View details on clinicaltrial.gov)

Showing 1 - 10 of 18 results